Impact Analysis of Covid-19
The complete version of the Report will include the impact of the COVID-19, and anticipated change on the future outlook of the industry, by taking into the account the political, economic, social, and technological parameters.
Metabolic Testing Market- Insights
Metabolic testing involves assessment of health and wellbeing of an individual. Metabolic testing equipment are used to screen organ functions and disease conditions such as liver diseases, diabetes, kidney diseases, and cardiovascular diseases. Metabolism is a chemical reaction occurring in the body to maintain the standard state of the organism or body. Metabolic syndrome is a group of metabolic disorders such as high blood pressure with high fasting glucose levels and abnormal obesity. Metabolism pattern and metabolic capacity is determined with the help of metabolic testing for management of such conditions. In case of sports professionals, metabolic testing is done in order to test body’s ability of oxygen consumption.
Launch and Approval of Advanced Metabolic Testing Devices
Key players in the market are focused on introducing advanced devices such as body composition analyzers, metabolic carts, and electrocardiogram (ECGs/EKGs). Key players such as InBody Co. Ltd., Korr Medical Technologies, Cosmed srl, Vyaire Medical, and OSI Systems, Inc. offer products in the market in different segments. For instance, in 2017, Cosmed received innovative technology designation from Vizient, Inc. for its K5 Wearable Metabolic System. The system comes with micro-dynamic mixing chamber or breath-by-breath gas exchange techniques, wireless connectivity, a standard USB port, and medical grade AC/DC power plug.
Moreover, portable VO2 max analysis devices have been introduced in the market by players such as VO2 Master. VO2 Master product VO2 Master Pro is a wearable VO2 analyzer with Bluetooth connectivity. AEI Technologies offers PC-based stress ECG system, which can turn any PC into an all-in-one cardiology system.
Furthermore, in October 2017, InBody Co., Ltd. launched InBody BAND 2 — a fusion of body composition analyzers and fitness trackers. InBody BAND 2 is capable of measuring percent body fat, fat mass, muscle mass, sleep monitoring, heart rate monitoring, and fitness tracking. Therefore, launch of advanced metabolic testing devices is expected to significantly boost metabolic testing market growth over the forecast period.
The global metabolic testing market size was valued at US$ 451.5 Mn in 2018, and is expected to witness a CAGR of 7.6% during the forecast period (2018 – 2026).
Figure 1. Global Metabolic Testing Market Share (%), By Product Type, 2018-2026
Source: Coherent Market Insights Analysis (2018)
Increasing Prevalence of Lifestyle Diseases is expected to Propel Demand for Metabolic Testing Devices
Metabolic testing market is expected to witness significant growth over the forecast period, owing to increasing prevalence of lifestyle diseases such as cardiovascular diseases, obesity, and type 2 diabetes. For instance, according to the World Health Organization (WHO), 2017, around 17 million deaths are registered worldwide, annually due to cardiovascular diseases, of which over three quarters are registered in low- and middle-income countries.
Moreover, according to American Diabetes Association (ADA), in 2015, around 30.3 million people in the U.S. were suffering from diabetes. Increasing prevalence of lifestyle diseases leads to high demand for metabolic testing, which in turn expected to boosts global metabolic testing market growth.
Figure 2. Global Metabolic Testing Market Share (%) Analysis, By Region, 2026
Source: Coherent Market Insights Analysis (2018)
Medical devices are classified into three categories: Class 1, Class 2, and Class 3. This classification is risk-based, where risk posed by the device to the patient represents category of the medical device. For instance, class 1 includes devices with lowest risk, class 2 includes medium risks, whereas class 3 includes devices with the highest risk.
The U.S. Food and Drug Administration (FDA) classifies metabolic testing devices into class II of medical device classification system. According to the U.S. FDA, if a device is classified into either class II (Special Controls) or class III, it may be subject to additional controls. The U.S. FDA classifies a device into class II (special controls) in order to provide a reasonable assurance of safety and effectiveness of the device.
Technological advancements in healthcare IT sector has enabled effective integration of complex healthcare and IT systems. Technologies such as cloud computing, data analytics, big data, and patient monitoring are majorly being used in healthcare.
This trend (connected health) has affected metabolic testing devices as well, as manufacturers are introducing portable/wearable devices with advanced features such as Bluetooth connectivity, inbuilt ECG monitors, fitness trackers, and other such multiple features.
However, metabolic testing is still not a necessity beyond situational requirement and metabolic testing is yet to reach its full potential. In such scenario, connected and portable metabolic testing devices may play a major role in enhancing the accessibility of metabolic testing. Examples of such devices include, K5 Wearable Metabolic System (manufactured by Cosmed srl), InBody BAND 2 (manufactured by InBody Co.,Ltd.), and VO2 Master Pro (manufactured by VO2 Master).
Key players operating in the metabolic testing market include, Cosmed srl, Vyaire Medical, Inc., Geratherm Medical AG, MGC Diagnostics Corporation, Cortex Biophysik GmbH, General Electric Company, Microlife Medical Home Solutions, Inc., OSI Systems, Inc., AEI Technologies, Inc., and Korr Medical Technologies, Inc.